Tretinoin: all 143 studies that test it
Page 2 of 2. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of PhotoagingCompletedNCT01406080Phase 3
- Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin CreamWithdrawnNCT01349556Not applicable
- Advanced Cervical Cancer Trial in IndiaCompletedNCT01276730Phase 2
- Retinoids in ANCA Small Vessel Vasculitis: Silencing AutoantigensWithdrawnNCT01275274Phase 2
- Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 MutationCompletedNCT01237808Phase 3
- Treatment Study for Children and Adolescents With Acute Promyelocitic LeukemiaStatus unknownNCT01226303Phase 3
- Combination Treatment for Moderate to Severe AcneCompletedNCT01206348Phase 4
- Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AMLCompletedNCT01161550Phase 1
- ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)WithdrawnNCT01067274Phase 3
- AIDA 2000 GuidelinesStatus unknownNCT01064570Phase 2
- "AIDA" Protocol (LAP 0493)Status unknownNCT01064557Not applicable
- Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung CancerCompletedNCT01048645Phase 2
- 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)WithdrawnNCT01048086Phase 2
- Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response BiomarkerStatus unknownNCT01041833Phase 3
- Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose CytarabineCompletedNCT00995332Phase 1/2
- Solar Lentigines Treatment With the Triple Combination CreamCompletedNCT00975312Phase 2
- Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00919555Phase 1/2
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic SyndromeCompletedNCT00892190Phase 1
- Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid LeukemiaCompletedNCT00867672Phase 2
- Efficacy and Safety of Oral Isotretinoin for Cutaneous PhotodamageStatus unknownNCT00842907Phase 2
- Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of MelasmaSuspendedNCT00717652Phase 2/3
- A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of RosaceaCompletedNCT00621218Phase 2
- APL93: Timing of CxT and Role of MaintenanceCompletedNCT00599937Phase 3
- ZD6474 Alone and in Combination With Retinoic Acid in Pediatric NeuroblastomaTerminatedNCT00533169Phase 1
- Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00514293Phase 2
- Phase III Trial in Acute Promyelocytic Leukemia PatientsCompletedNCT00482833Phase 3
- Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic AcidStatus unknownNCT00437450Phase 2
- Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)CompletedNCT00408278Phase 4
- Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical TretinoinTerminatedNCT00240513Phase 4
- Differentiation Induction in Acute Myelogenous LeukemiaCompletedNCT00175812Phase 1/2
- All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00151255Phase 3
- Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00151242Phase 2/3
- A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNCT00136461Phase 2
- Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerCompletedNCT00100906Phase 2
- Phenylbutyrate and Tretinoin in Treating Patients With Hematologic CancerCompletedNCT00006239Phase 1
- Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyTerminatedNCT00006220Phase 1/2
- Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's DiseaseWithdrawnNCT00005969Phase 2
- Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00005863Phase 3
- Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus SyndromeCompletedNCT00003601Phase 2
- UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical NeoplasiaCompletedNCT00003598Not applicable
- Tretinoin in Treating Patients With Mycosis Fungoides or Sezary SyndromeCompletedNCT00002479Phase 2
- A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' TumorCompletedNCT00001509Phase 2
- A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency SyndromesCompletedNCT00001438Phase 2